Synthetic Scaffold Composite Materials for Perfusion and Transplant Fit
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current techniques for producing engineered tissues or organs using scaffolds either decellularize natural organs or mimic their shape with synthetic materials, failing to address the need for structural and functional features that do not replicate all aspects of biological scaffolds, and lack compatibility with transplantation sites.
Innovation Solution
A synthetic scaffold is designed using a combination of two or more materials and manufacturing techniques to provide structural and functional properties, including perfusion pathways for material distribution and cellularization, mimicking natural structures while being compatible with transplantation sites.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If natural organs are decellularized to produce scaffolds, then structural support is provided, but functional performance and compatibility with transplantation sites are insufficient
Solution Approach 1:
The patent employs composite materials combining natural extracellular matrix components (collagen, elastin, fibronectin) with synthetic polymers (PLGA, PCL, chitosan) to create scaffolds that simultaneously provide structural support and enhance biocompatibility. The natural components offer structural integrity while synthetic components improve degradation control and cellular interaction, resolving the contradiction between strength and adaptability.
Solution Approach 2:
The scaffold design implements local quality by creating region-specific structures with varying porosity, pore size, and material composition tailored to different transplantation site requirements. Different zones of the scaffold have optimized properties for specific functions such as vascularization, cell attachment, or nutrient diffusion, enabling compatibility with diverse transplantation sites while maintaining overall structural support.
2Shape
If synthetic materials are configured to mimic natural scaffold shape, then structural support is achieved, but functional features for material distribution and cellularization are lacking
Solution Approach 1:
The patent utilizes porous materials with controlled pore sizes, porosity levels, and interconnected pore networks that mimic natural extracellular matrix architecture. These porous structures enable efficient material distribution throughout the scaffold, facilitate cell infiltration and proliferation, and support vascularization, thereby providing the functional features for cellularization while maintaining the shape of natural scaffolds.
Solution Approach 2:
The scaffold design incorporates three-dimensional vascular networks and perfusion channels that add functional dimensions to the structural framework. These internal three-dimensional pathways enable material distribution and cellularization throughout the bulk of the scaffold, transforming a purely structural form into a functionally active structure capable of supporting tissue engineering.
3Stability of the object's composition
If all aspects of biological scaffolds are replicated, then structural fidelity is improved, but manufacturing complexity and cost increase
Solution Approach 1:
The patent divides the scaffold into modular segments or layers, each fabricated using optimized manufacturing techniques for specific functional requirements. This segmentation allows different portions of the scaffold to be manufactured independently with appropriate materials and structures, then assembled into a complete scaffold that replicates essential biological features without requiring complete replication of all natural complexities.
Solution Approach 2:
The scaffold design employs parameter changes by systematically varying material composition, porosity, pore size, and structural geometry to achieve optimal balance between biological fidelity and manufacturability. Rather than replicating all natural features, critical parameters such as pore size distribution, degradation rate, and mechanical properties are optimized to match essential biological functions while simplifying manufacturing processes.
Data Source
AI summary
Aspects of this disclosure relate to a combination of techniques and/or materials that can be used to form a synthetic scaffold for solid and/or hollow organs or tissue. In some embodiments, methods are provided that involve assembling a synthetic scaffold using a first material for a first structural component and a second material for a second structural component, in which the first or second structural component in a perfusion pathway. In some embodiments, materials (e.g. synthetic materials) for the scaffold are printed, molded, cast, polymerized or electrospun. In some embodiments, a scaffold may mimic a natural scaffold or several features of a natural scaffold.